TNGN Stock UPDATES Tengion (TNGN) 0.1500 08/11/2014 08:59:37

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Tengion (TNGN) 0.1500 $TNGN

Tengion Reports Fourth Quarter and Full Year 2013 Financial Results
GlobeNewswire - Wed Mar 26, 3:05PM CDT
Tengion, Inc. (OTCQB:TNGN), a leader in regenerative medicine, today reported its financial results for the fourth quarter and full year ended December 31, 2013 and provided a business update.

Tallwave Expands High Tide Lean Business Competition to Include Ed Tech and Healthcare IT From Across the Country and Adds Industry Agnostic "Wildcard" Slots for Arizona IT Startups
Marketwire - Thu Mar 13, 2:14PM CDT
Tallwave today announced it is opening applications in its latest High Tide(TM) competition to Healthcare IT entrepreneurs from across the country. These entrepreneurs will join peers applying for the program in the previously announced focus on innovations in Ed Tech. In addition, Tallwave has reserved four to six slots for Arizona-only IT companies regardless of the industry sector they hail from. The deadline for submission is March 31, 2014 and can be completed online at www.tallwavehightide.com.

Tengion to Present at the 26th Annual ROTH Conference
GlobeNewswire - Tue Mar 04, 3:30PM CST
Tengion, Inc. (OTCQB:TNGN), a leader in regenerative medicine, today announced that John L. Miclot, President and Chief Executive Officer of Tengion, will present at the upcoming 26th Annual ROTH Conference on Monday, March 10, 2014, at 12:30 p.m. PDT in Dana Point, CA.

Global Stem Cell Market Report 2013
M2 - Tue Dec 17, 4:54AM CST
Research and Markets (http://www.researchandmarkets.com/research/qsfq7f/stem_cell_markets) has announced the addition of the "Global Stem Cell Market Report 2013" report to their offering. Traditionally, stem cells have been classified as either embryonic, adult (tissue-specific or cord blood) stem cells. However, recent understanding of stem cell biology may provide new approaches for the treatment of a number of diseases as well as tissue/organ injuries, including cardiovascular disease, neurological disease, musculoskeletal disease, diabetes and hematopoietic disorders. Stem cell fate is determined by both intrinsic regulators and the extra-cellular environment (niche), and their expansion and differentiation ex vivo are generally controlled by growing them in a specific configuration (monolayer or three-dimensional culture). This process, which is vital to enable stem cells to be used for therapeutic purposes, is called differentiation. Differentiation is a process involving unspecialized cells progressing to become specialized cells with restricted developmental potential. "Global Stem Cell Market Report 2013", describes the specific market segments of the medical research space using stem cells for research and development (R&D) purposes. This study reviews all of the generally accepted analytical methods that are currently in use today for preparing and using stem cells. Key Topics Covered: 1. Overview 2. Biology of Stem Cells 3. Stem Cell Therapy 4. Market Analysis of the Stem Cell Space 5. Strategic Roadmap to Cell Therapy Industry 6. Funding for Regenerative Medicine Research 7. Current Stem Cell Research 8. Company Profiles Companies Mentioned: - Athersys, Inc - Brainstorm Cell Therapeutics, Inc - CryoLife, Inc - Epistem PLC - Forticell Bioscience, Inc - Glycosan Biosystems, Inc - Humacyte, Inc - International Stem Cell Corporation - Japan Tissue Engineering Co., Ltd - LifebankUSA - Miltenyi Biotec - Novocell, Inc - Osiris Therapeutics, Inc - Pluristem Therapeutics, Inc - ReNeuron Group Plc - Stempeutics Research Private Limited - Tengion, Inc - VistaGen Therapeutics, Inc - ZenBio, Inc For more information visit http://www.researchandmarkets.com/research/qs...ll_markets

Tengion Provides Business Update and Reports Second Quarter 2013 Financial Results
PR Newswire - Wed Aug 14, 3:05PM CDT
Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today provided a business update and reported its financial results for the second quarter ended June 30, 2013.

OTC Daily Alert Stock Watch - Tengion (OTCQB: TNGN)
WorldStockWire - Sat Aug 10, 7:00PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com

Tengion Announces Promotion of A. Brian Davis to Chief Financial Officer and Senior Vice President, Finance
PR Newswire - Wed Aug 07, 7:30AM CDT
Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today announced the promotion of A. Brian Davis to Chief Financial Officer and Senior Vice President, Finance. Mr. Davis has served as Chief Financial Officer of Tengion since joining the Company in 2010 and recently helped facilitate the Company in raising $33.6M to fund research and development activities for its two lead clinical programs, the Neo-Kidney Augment(TM) and the Neo-Urinary Conduit(TM).

Market Maker Surveillance Report. OSTK, STXS, ZHNE, TNGN, GAME, HGSH, Winning Stocks With Lowest Price Friction For Thursday, July 18th 2013
M2 - Fri Jul 19, 2:05AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Thursday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Thursday there were 3821 companies with "abnormal" market making, 3241 companies with positive Friction Factors and 1918 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Thursday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Overstock.com Inc (NASDAQ:OSTK), Stereotaxis Inc (NASDAQ:STXS), Zhone Technologies Inc (NASDAQ:ZHNE), Tengion Inc (OTC:TNGN), Shanda Games Ltd (NASDAQ:GAME), China Hgs Real Estate Inc (NASDAQ:HGSH). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Tengion Announces Transactions Totaling $33.6 Million to Advance its Organ Regeneration Platform(TM)
PR Newswire - Mon Jul 01, 1:41PM CDT
Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today announced the closing of transactions totaling $33.6 million to fund its two lead clinical programs, the Neo-Kidney Augment(TM) and the Neo-Urinary Conduit(TM).

Tengion to Participate in Panel Discussion at ISSCR 11th Annual Meeting
PR Newswire - Wed Jun 12, 3:30PM CDT
Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today announced that Dr. Tim Bertram, the Company's President of Research and Development and Chief Scientific Officer, will participate in a panel at the International Society for Stem Cell Research (ISSCR) 11th Annual Meeting being held June 12th-15th, 2013 in Boston, Massachusetts.

Tengion Provides Business Update and Reports First Quarter 2013 Financial Results
PR Newswire - Wed May 15, 7:30AM CDT
Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today provided a business update and reported its financial results for the first quarter ended March 31, 2013.

Tengion Receives MPA Approval of CTA for Neo-Kidney Augment Phase 1 Trial in Sweden
PR Newswire - Mon Apr 01, 7:30AM CDT
Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today announced the acceptance of the Company's Clinical Trial Application (CTA) filed with the Medical Products Agency (MPA) in Sweden to initiate a Phase 1 clinical trial to evaluate the safety and delivery of its Neo-Kidney Augment(TM) product in up to five patients with advanced chronic kidney disease (CKD).

Tengion Provides Business Update and Reports Fourth Quarter and Full Year 2012 Financial Results
PR Newswire - Mon Mar 18, 6:30AM CDT
Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today reported its financial results for the fourth quarter and full year ended December 31, 2012 and provided a business update.

Tengion to Present at 25th Annual ROTH Conference
PR Newswire - Tue Mar 12, 7:30AM CDT
Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today announced that John L. Miclot, President and Chief Executive Officer of Tengion, will present at the upcoming 25th Annual ROTH Conference on Tuesday, March 19, 2013, at 2:00 p.m. PDT in Laguna Niguel, CA.

Tengion to Host Conference Call to Provide a Business Update and Report Fourth Quarter and Full Year 2012 Financial Results on March 18, 2013
PR Newswire - Mon Mar 11, 3:00PM CDT
Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today announced it will host a conference call and live audio webcast on Monday, March 18, 2013, at 9:00 a.m. EDT to provide a business update and discuss its fourth quarter and full year 2012 financial results.

Tengion to Present at the BIO CEO & Investor Conference
PR Newswire - Tue Feb 05, 7:00AM CST
Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today announced that A. Brian Davis, Chief Financial Officer and Vice President, Finance of Tengion, will present at the upcoming BIO CEO & Investor Conference on Tuesday, February 12, 2013, at 10:30 a.m. EST in New York City.

Tengion Announces Clinical Progress for Neo-Urinary Conduit(TM) Phase 1 Trial and Regulatory Advance for Neo-Kidney Augment(TM)
PR Newswire - Wed Jan 30, 3:30PM CST
Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today announced advances for its two lead programs, the Neo-Urinary Conduit(TM) and Neo-Kidney Augment(TM).

Tengion Announces Change to Board of Directors
PR Newswire - Fri Dec 21, 7:15AM CST
Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today announced that Scott D. Flora, President & Chief Executive Officer at OmniGuide, has resigned from Tengion's Board of Directors, effective December 19, 2012.

Regenerative Medicine - Global Strategic Business Report
M2 - Mon Dec 17, 4:19AM CST
Research and Markets (http://www.researchandmarkets.com/research/qhqtfr/regenerative) has announced the addition of the "Regenerative Medicine - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Regenerative Medicine in US$ million. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. A six-year historic analysis is also provided for these markets. The report profiles 93 companies including many key and niche players such as: - BioVest International Inc. - Curis Inc. - Cytori Therapeutics Inc. - Evotec AG - Forticell Bioscience Inc. - Geron Corporation - Integra LifeSciences Corporation - LifeCell Corporation - Osiris Therapeutics Inc. - Tengion Inc. - Tepha Inc. - TiGenix N.V. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public doma




Scroll down for more posts ▼

Top 10 Most Recent News Articles

ZAKSIMLAB Tests Kombucha and Salmon Snack Pairing in Cafes

Updated Category News Views 48

A fish-based chip beside a fizzy tea mix is an odd little commercial wager, and that is exactly why ZAKSIMLAB's latest move deserves a look. The Seoul food brand launched Salmon Crunch Protein Chips in September, then put the snack next to its powdered kombucha at the 2026 Cafe & Bakery Fair Season 2. This is not a grand earnings story; no sales, pricing, store-count, or...

Continue Reading
Vusion Lands a 2,000-Store dm EdgeSense Rollout in Germany

Updated Category News Views 135

A drugstore shelf rarely gets anyone's pulse racing, but 2,000 of them wired into a live digital system is a serious retail deployment. Vusion has expanded its partnership with dm-drogerie markt to roll out its newest EdgeSense platform across about 2,000 German stores over the next three years. This is not a glossy one-store pilot with a ribbon-cutting and a few tablets...

Continue Reading
Chaos Zero Nightmare's Award Is a Useful Signal for Games

Updated Category News Views 189

A story award can be easy to sneer at until a live-service game earns one across three markets. Smilegate's Chaos Zero Nightmare, a dark fantasy roguelike RPG developed by Super Creative, was named Best Story in Google Play's Best of 2026 awards for Taiwan, Hong Kong and Macau. That is not a sales figure, not a profit disclosure, and certainly not proof that a hit has...

Continue Reading
Scalefusion’s Platinum Win Sharpens Its Brand Story

Updated Category News Views 14

A Film Is Not a Balance Sheet A slick brand film cannot patch a leaky product, but it can make a complicated platform easier to remember. That is the sensible takeaway from Scalefusion’s Platinum Level win at the 2026 MarCom Awards for “One Platform. One Agent. We are Scalefusion.” The recognition is for creative execution, not commercial performance, and anybody...

Continue Reading
AMPERA Joins Berto to Power Future Energy Innovations

Updated Category News Views 172

The Power Play You Didn't See Coming AMPERA and Berto just made a move that could stir up some serious waves in the energy sector. They've inked a business combination deal set to push advanced energy technology to the forefront. With AMPERA's valuation clocking in at roughly $900 million, this partnership aims to bring cutting-edge power solutions from concept to market....

Continue Reading
My Home Delivery's Bold Move in Big & Bulky Sector

Updated Category News Views 194

Redefining Big & Bulky Deliveries with AI Let me tell you, the logistics world isn't for the timid, and My Home Delivery (MHD) is swinging for the fences with their latest tech platform. These folks are rolling out an AI-driven system that promises to turn the bulky goods market on its head. Imagine moving your brand new fridge or that king-size bed across town without...

Continue Reading
Mike Blyth’s Hall of Fame Honors a Builder’s Legacy

Updated Category News Views 147

Recognition earned in the hangar, not a boardroom Aircraft design has a ruthless way of exposing empty talk, which is why Mike Blyth’s November 11 induction into the EAA Homebuilders Hall of Fame carries real weight. The Experimental Aircraft Association’s honor, presented in the Eagle Hangar at the EAA Aviation Museum in Oshkosh, Wisconsin, recognizes a career built...

Continue Reading
ISDN Holdings: Leading APAC Automation with Innovation

Updated Category News Views 81

Pioneering Automation Intelligence in APAC Not every day you hear a company quietly revolutionizing an entire industry's landscape—but ISDN Holdings Limited is one of those rare players. Recognized by Frost & Sullivan for its top-tier customer value leadership, ISDN is making waves across the Asia-Pacific's industrial scene with its integrated industrial automation...

Continue Reading
MacDill Mold Case Puts Privatized Housing on Notice

Updated Category News Views 89

Four hundred fifty-four people are a hard number to shrug off. The expanded civil case over alleged toxic mold conditions at MacDill Air Force Base now covers 105 military families, up from 39 households when it was filed in September 2025. Their complaint against The Michaels Organization and affiliated entities may be the largest known military-housing lawsuit in the...

Continue Reading
Toledo Crosswalk Death Lawsuit Raises Hard Questions

Updated Category News Views 237

A painted crosswalk is supposed to mean something, and that is the grim center of the lawsuit filed over Judy Tanner’s death in Toledo. Tanner, 20, was walking home from work on September 10, 2026, when she was struck and killed while crossing the street. Her estate is now suing, alleging that the 31-year-old driver failed to yield as Tanner legally used the crosswalk....

Continue Reading

Top 5 Most Recently Viewed Articles

Olo Inc. Under Investigation for Potential Fiduciary Violations

Updated Category News Views 255

Olo Inc. Faces Investigation Over Fiduciary Duties Olo Inc. is currently under investigation by legal authorities due to possible breaches of fiduciary duty by its directors and management. This scrutiny follows Olo's announcement regarding a major acquisition deal with investment firm Thoma Bravo, valued at around $2 billion. Details of the Investigation The focus of the...

Continue Reading
Join MT Højgaard Holding's Conference Call on FY 2024 Results

Updated Category News Views 115

MT Højgaard Holding A/S Conference Call Overview MT Højgaard Holding is set to release its annual report for the fiscal year 2024 on a chosen date. Following this release, a conference call will take place where the management team will delve into the company’s performance and projections for the future. This session aims to provide insights into the results for the...

Continue Reading
ClearValue Consulting Partners with Restb.ai for Advanced Appraisals

Updated Category News Views 77

Unlocking Efficiency in Appraisal Reviews ClearValue Consulting, a leader in innovative valuation solutions, has announced an exciting new partnership with Restb.ai, a prominent name in AI-powered computer vision. This collaboration is set to redefine the appraisal review landscape, bringing in advanced technologies to streamline processes and enhance quality. The Impact...

Continue Reading
BrightSphere's Transformation: New Name and Leadership Direction

Updated Category News Views 393

BrightSphere Investment Group Inc. (NYSE: BSIG) announced its rebranding to Acadian Asset Management back in early 2025, marking a major shift in strategy. This wasn't just a name change; it was the end of their multi-boutique model and the start of a more streamlined focus on asset management. They offloaded six out of seven affiliates to zero in on core...

Continue Reading
Why Super Micro Computer’s Growth Could Still Continue

Updated Category News Views 339

Super Micro Computer (NASDAQ: SMCI) kicked off 2024 like a rocket, watching its stock explode by an eye-popping 188% in the first half. It was a remarkable performance that even left tech giants scrambling for a second look. The surge stemmed largely from surging demand for their cutting-edge workstations and servers—essential cogs in the booming artificial intelligence...

Continue Reading